Body mass index is inversely associated with mortality in patients with peripheral vascular disease

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 549-555

  Golledge, Jonathan ^a,b   Cronin, Oliver ^a,b   Iyer, Vikram ^a,b   Bradshaw, Barbara ^a,b   Moxon, Joseph V ^a,b   Cunningham, Maggie A ^a,b  

^a JAMES COOK UNIVERSITY   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Mortality; Obesity; Peripheral vascular disease; Underweight

Indexed keywords

ABDOMINAL FAT; ABDOMINAL SUBCUTANEOUS FAT; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DYING; FEMALE; HUMAN; INTRAABDOMINAL FAT; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL VASCULAR DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNDERWEIGHT; WAIST CIRCUMFERENCE;

MORTALITY; OBESITY; PERIPHERAL VASCULAR DISEASE; UNDERWEIGHT;

AGED; AGED, 80 AND OVER; BODY COMPOSITION; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OBESITY; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; THINNESS; WAIST CIRCUMFERENCE;

EID: 84880507458     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.04.030     Document Type: Article

References (55)

1. Seidell J.C., Verschuren W.M., van Leer E.M., et al. Overweight, underweight, and mortality. A prospective study of 48,287 men and women. Arch Intern Med 1996, 156:958-963.
2. Adams K.F., Schatzkin A., Harris T.B., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. NEngl J Med 2006, 355:763-778.
3. Bogers R.P., Bemelmans W.J., Hoogenveen R.T., et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: ameta-analysis of 21 cohort studies including more than 300,000 persons. Arch Intern Med 2007, 167:1720-1728. for the BMI-CHD Collaboration Investigators.
4. Calle E.E., Thun M.J., Petrelli J.M., et al. Body-mass index and mortality in a prospective cohort of U.S. adults. NEngl J Med 1999, 341:1097-1105.
5. Smith S.C., Benjamin E.J., Bonow R.O., et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. JAm Coll Cardiol 2011, 58:2432-2446.
6. Orepoulos A., Padwal R., Kalantar-Zadeh K., et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156:13-22.
7. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368:666-678.
8. Angeras O., Albertsson P., Karason K., et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish coronary angiography and angioplasty registry. Eur Heart J 2013, 34:345-353.
9. Vaduganathan M., Lee R., Beckham A.J., et al. Relation of body mass index to late survival after valvular heart surgery. Am J Cardiol 2012, 110:1667-1678.
10. Tseng C.H. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus. Atherosclerosis 2013, 226:184-190.
11. Zafrir B., Adir Y., Shehadeh W., et al. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the obesity paradox. Respir Med 2013, 107:139-146.
12. Jialin W., Yi Z., Weijie Y. Relationship between body mass index and mortality in hemodialysis patients: a meta-analysis. Nephron Clin Pract 2012, 121:c102-c111.
13. Miller M., Delaney C., Penna D., et al. A3-year follow-up study of inpatients with lower limb ulcers: evidence of an obesity paradox?. JMultidiscip Health 2012, 5:181-186.
14. Kim B.J., Lee S.H., Jung K.H., et al. For Korean Stroke Registry investigators. Neurology 2012, 79:856-863.
15. Ovbiagele B., Bath P.M., Cotton D., et al. Obesity and recurrent vascular risk after a recent ischemic stroke. Stroke 2011, 42:3397-3402.
16. Lavie C.J., De Schutter A., Patel D.A., et al. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the obesity paradox. JAm Coll Cardiol 2012, 60:1374-1380.
17. Layden J., Michaels J., Bermingham S., et al. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. BMJ 2012, 345:e4947. Guideline Development Group.
18. Rooke T.W., Hirsch A.T., Misra S., et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2011, 58:2020-2045.
19. Tendera M., Aboyans V., Bartelink M.L., et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011, 32:2851-2906. European Stroke Organisation, ESC Committee for Practice GuidelinesESC Committee for Practice Guidelines.
20. Nicolaides A.N., Allegra C., Bergan J., et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol 2008, 27:1-59.
21. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006, 295:180-189. REACH Registry Investigators.
22. Mukherjee D., Lingam P., Chetcuti S., et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions. Circulation 2002, 106:1909-1912.
23. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the REACH Registry. Atherosclerosis 2009, 204:e86-e92. REACH Registry Investigators.
24. Wassink A.M., van der Graaf Y., Olijhoek J.K., et al. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2008, 29:213-223. SMART Study Group.
25. van Kuijk J.P., Flu W.J., Chonchol M., et al. Metabolic syndrome is an independent predictor of cardiovascular events in high-risk patients with occlusive and aneurysmatic peripheral arterial disease. Atherosclerosis 2010, 210:596-601.
26. Smolock C.J., Anaya-Ayala J.E., Bismuth J., et al. Impact of metabolic syndrome on the outcomes of superficial femoral artery interventions. JVasc Surg 2012, 55:985-993.
27. Brevetti G., Laurenzano E., Giugliano G., et al. Metabolic syndrome and cardiovascular risk prediction in peripheral arterial disease. Nutr Metab Cardiovasc Dis 2010, 20:676-682.
28. Vlek A.L., van der Graaf Y., Sluman M.A., et al. Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease. JVasc Surg 2009, 50:61-69. SMART Study Group.
29. Golledge J., Leicht A., Crowther R.G., et al. Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication. JVasc Surg 2007, 45:40-46.
30. Le Hello C., Morello R., Fradin S., et al. Beware of suboptimal medical management of patients with atherosclerosis requiring revascularization. Int Angiol 2012, 31:260-270.
31. Tanaka S., Sakata R., Marui A., et al. Predicting long-term mortality after first coronary revascularization: the Kyoto model. Circ J 2012, 76:328-334. CREDO-Kyoto Investigators.
32. Kanhai D.A., Kappelle L.J., van der Graaf Y., et al. The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease. Int J Obes 2012, 36:695-702. SMART Study Group.
33. Kumakura H., Kanai H., Aizaki M., et al. The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease. JVasc Surg 2010, 52:110-117.
34. Barba R., Bisbe J., Pedrajas J.N., et al. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry. Eur J Cardiovasc Prev Rehabil 2009, 16:457-463. FRENA Investigators.
35. Galal W., van Gestel Y.R., Hoeks S.E., et al. The obesity paradox in patients with peripheral arterial disease. Chest 2008, 134:925-930.
36. Gardner A.W., Montgomery P.S., Parker D.E. Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. JVasc Surg 2008, 47:117-122.
37. McDermott M.M., Liu K., Tian L., et al. Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. JAm Coll Cardiol 2012, 59:1159-1167.
38. Chan M., Kelly J., Batterham M., et al. Malnutrition (subjective global assessment) scores and serum albumin levels, but not body mass index values, at initiation of dialysis are independent predictors of mortality: a 10-year clinical cohort study. JRen Nutr 2012, 22:547-557.
39. Blum A., Sirchan R., Abu-Shkara F., et al. Abdominal circumference and recurrent hospitalizations may affect the clinical outcome of patients with acute heart failure. Exp Clin Cardiol 2011, 16:40-42.
40. Abbas A.E., Goodman L.M., Timmis R., et al. Predictors of poor outcome in female patients undergoing endovascular intervention. JInterv Cardiol 2010, 23:401-410.
41. Urbonaviciene G., Frystyk J., Flyvbjerg A., et al. Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial disease. Atherosclerosis 2010, 210:619-624.
42. Kalbaugh C.A., Taylor S.M., Kalbaugh B.A., et al. Does obesity predict functional outcome in the dysvascular amputee?. Am Surg 2006, 72:707-712.
43. Garg P.K., Tian L., Criqui M.H., et al. Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation 2006, 114:242-248.
44. Jager A., Kostense P.J., Ruhé H.G., et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999, 19:617-624.
45. Peduzzi P., Concato J., Kemper E., et al. Asimulation study of the number of events per variable in logistic regression analysis. JClin Epidemiol 1996, 49:1373-1379.
46. Porter J.M., Moneta G.L. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. JVasc Surg 1995, 21:635-645.
47. Palamuthusingam D., Quigley F., Golledge J. Implications of the finding of no significant carotid stenosis based on data from a regional Australian vascular unit. Ann Vasc Surg 2011, 25:1050-1056.
48. Parr A., Buttner P., Shahzad A., et al. Relation of infra-renal abdominal aortic calcific deposits and cardiovascular events in patients with peripheral artery disease. Am J Cardiol 2010, 105:895-899.
49. Golledge J., Jayalath R., Oliver L., et al. Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. Atherosclerosis 2008, 197:428-434.
50. Parr A., McCann M., Bradshaw B., et al. Thrombus volume is associated with cardiovascular events and aneurysm growth in patients who have abdominal aortic aneurysms. JVasc Surg 2011, 53:28-35.
51. Magee R., Quigley F., McCann M., et al. Growth and risk factors for expansion of dilated popliteal arteries. Eur J Vasc Endovasc Surg 2010, 39:606-611.
52. Golledge J., Clancy P., Jamrozik K., et al. Obesity, adipokines, and abdominal aortic aneurysm: health in men study. Circulation 2007, 116:2275-2279.
53. World Health Organisation Obesity and overweight. Fact sheet number 311 Available at:, Viewed on 31/12/2012. http://www.who.int/mediacentre/factsheets/fs311/en/.
54. Taylor J. The obesity paradox. Eur Heart J 2011, 32:1575-1576.
55. Speakman J.R. Sex and age-related mortality profiles during famine. JBiosoc Sci 2013, 10:1-18.